(Q47860548)

English

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein

scientific article published in June 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Chalmers K

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

Wilcock GK

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

Love S

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

Neuropathology and Applied Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

29

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

231-238

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

The role of cerebral ischemia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Apolipoprotein E genotyping by one-stage PCR

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00457.X

21 January 2018

Identifiers

10.1046/J.1365-2990.2003.00457.X

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/12787320

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47860548&oldid=2173004136"